In Depth 24 Apr 2024
Overcoming toxicities: are IL-2 smart cytokines the next big thing?
…(FDA) for the treatment of mucosal melanoma, a type of rare and aggressive cancer that begins in the tissues that line organs. It has also gained the fast track designation…